Fight COVID with germicidal UV-C

In a recent study conducted by Fujita Health University, Japan, a live COVID-19 strain was used to perform antimicrobial effectiveness testing using Diversey MoonBeam3 on SARS-CoV-2 (see press release for full details). The results: At four seconds, MoonBeam3 left no detectable organisms, a 99.9999% (>6 log 10) reduction.
MoonBeam3 is THE FIRST AND ONLY UV-C 254 nanometer system proven to destroy coronavirus AND in under four seconds.

In addition to coronavirus, MoonBeam3 is built and tested against healthcare-associated infection (HAI) reduction. It uses UV-C in the 254-nanometer germicidal spectrum, effective on enveloped and non-enveloped viruses.

Viruses are often characterized according to the presence/absence of an envelope, the form of their nucleic acid (single-stranded [ss] or double-stranded [ds]), and the type of nucleic acid (RNA or DNA). SARS-CoV-2 is an enveloped virus – that is, the outer layer is a lipid membrane which is taken from the host cell in which the virus multiplies. Like other CoVs, it is sensitive to ultraviolet rays and heat, and highly susceptible to germicidal UV irradiation.

Moonbeam™3 is the first and only UV-C 254 nanometer system proven to destroy SARS-CoV-2 (Coronavirus). And in under 4 seconds!
OCTOBER 2, 2020

The system’s compact size and mobility enables a user to uniquely direct UV-C light to horizontal, vertical and angled surfaces providing maximum reach and helping to eliminate shadow areas. MoonBeam3 gets the dose close which significantly increases disinfection effectiveness.

MoonBeam3 is third-party antimicrobial effectiveness tested on a broad range of pathogens, including enveloped and non-enveloped viruses

The table below shows that the susceptibility of coronavirus to UV is greater than 3 times compared to the influenza (common cold) virus:

As an adjunct to wipes and chemical cleaning, MoonBeam3 technology is extremely effective with >4 log reductions verified. MoonBeam3 tests on non-enveloped and enveloped viruses including coxsackieviruses, rotavirus, or poliovirus documented high-log reduction.